Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China

Table 4 Univariate analysis of variable associated with death for COVID-19 patients

Variable	Univariable
Variable	OR (95% CI)	P value
Age	1.102 (1.054–1.152)	< 0.001*
Male	6.114 (1.662–22.485)	0.006*
Hypertension	5.000 (1.748–14.301)	0.003*
Diabetes	4.881 (1.310–18.184)	0.018*
Cardiovascular disease	7.972 (2.290–27.753)	0.001*
White blood cell count	1.239 (1.055–1.455)	0.009*
Neutrophil count	1.257 (1.073–1.472)	0.005*
Lymphocyte count	0.234 (0.051–1.075)	0.062
Platelet count	0.987 (0.977–0.997)	0.009*
Prothrombin time	1.084 (0.737–1.595)	0.683
Activated partial thromboplastin time	0.998 (0.979–1.017)	0.829
Creatine kinase	1.001 (0.999–1.002)	0.277
Creatine kinase-MB	1.043 (1.008–1.079)	0.015*
Lactate dehydrogenase	1.006 (1.002–1.010)	0.004*
Alanine aminotransferase	1.020 (1.002–1.038)	0.031*
Aspartate aminotransferase	1.034 (1.015–1.054)	< 0.001*
Total bilirubin	1.070 (0.995–1.149)	0.066
Blood urea nitrogen	1.001 (0.985–1.016)	0.943
Creatinine	1.037 (1.015–1.058)	0.001*
Tamiflu	0.389 (0.047–3.209)	0.380

ISSN: 1364-8535